ANIP
NASDAQ · Pharmaceuticals
Ani Pharmaceuticals Inc
$79.49
-1.03 (-1.28%)
Open$81.00
Previous Close$80.52
Day High$81.00
Day Low$78.38
52W High$99.50
52W Low$62.61
Volume—
Avg Volume273.3K
Market Cap1.81B
P/E Ratio19.62
EPS$4.29
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-53.8% upside
Current
$79.49
$79.49
Target
$36.71
$36.71
$28.36
$36.71 avg
$54.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 922.38M | 655.05M | 587.23M |
| Net Income | 81.80M | 52.28M | 76.98M |
| Profit Margin | 8.9% | 8.4% | 13.1% |
| EBITDA | 211.45M | 142.66M | 125.34M |
| Free Cash Flow | — | — | 59.62M |
| Rev Growth | +40.8% | +40.8% | +23.0% |
| Debt/Equity | 1.14 | 1.14 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |